Market Overview

Top 4 Stocks In The Drug Delivery Industry With The Highest EPS Estimates For The Next Quarter

Related HSP
Could M&A Boost Pfizer More? Jefferies Thinks So
Credit Suisse: We Prefer Pfizer, Bristol Over Pharma Peers
IRadimed Hits 52-Week High, Pump Demand Key Catalyst - Analyst Blog (Zacks)
Related PETS
Amazon Hits New 52-Week High
What Google's YouTube Is Doing For Kids
No Bosses for Zappos, What About its Parent - Amazon? - Analyst Blog (Zacks)

Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next quarter.

Hospira (NYSE: HSP) is estimated to post earnings of $0.51 per share in the March quarter. Hospira's trailing-twelve-month revenue is $4.01 billion.

PetMed Express (NASDAQ: PETS) is expected to earn $0.19 per share in the March quarter. PetMed Express's PEG ratio is 2.96.

Alkermes plc (NASDAQ: ALKS) is likely to earn $0.16 per share in the March quarter. Alkermes had $199.45 million in total cash for the latest quarter.

Elan Corporation plc (NYSE: ELN) may earn $0.09 per share in the March quarter. Elan's trailing-twelve-month operating margin is 11.65%.

Posted-In: Drug Delivery Industry Highest EPS EstimatesTrading Ideas


Related Articles (ALKS + ELN)

Around the Web, We're Loving...